Knee Injections for Obese Patients With Knee Arthritis
Recruiting · NCT06782529 · Interventional (participants receive a specific treatment) · Lead sponsor: Mayo Clinic
View the official record on ClinicalTrials.gov →Interventions studied
Triamcinolone Acetonide Low DoseTriamcinolone Acetonide Standard Dose
What this trial is about
The purpose of this study is to assess obese patients with knee arthritis and determine the non-inferiority of a low dose steroid treatment vs. standard dose steroid treatment for two knee outcome measures: pain and function.
Who can take part
Age range
55 Years to 85 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Phase 4
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Patients with BMI ≥30 kg/m2 and radiograph-proven knee osteoarthritis who are interested in receiving a steroid injection for knee arthritis.
Exclusion criteria
- BMI \< 30 kg/m2
- Uncontrolled diabetics with a hemoglobin A1c \> 8%
- No other treatment within the time frame of the study.
- Patients that are undergoing physical therapy at the time of the study.
Where it is running
2 locations listed across 1 US state.
- Mayo Clinic in Florida - Jacksonville, Florida, United States
- Mayo Clinic in Florida - Jacksonville, Florida, United States